Mesa Laboratories, Inc. (MLAB) Stock: Price, Forecast & Analyst Target
Mesa Laboratories, Inc. (MLAB) — MoonshotScore 42/100 (Weak band), calculated Nov 18, 2026. Price $137.81 (+2.38%), as of the Nov 18, 2026 trading session; market cap $775M.
Educational signal · not a buy or sell recommendation · How to read this
Mesa Laboratories, Inc. · MLAB · NASDAQ
Mesa Laboratories, Inc. is a technology company specializing in life sciences tools and quality control products.
Price as of Nov 18, 2026
Key Statistics
MoonshotScore v2 · Mesa Laboratories (MLAB)
WeakWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
High quality and elite growth, but a full valuation. The score also carries a risk penalty for reported profit not backed by cash flow. Business Quality: Elite; Financial Safety: Okay; Valuation: Full; Growth Durability: Compounding; Momentum: Surging.
- EPS beat 1 of the last 4 reports
- Altman Z 2.43 · Piotroski F 7
- ROE 3.6% · ROA 3.9% · current ratio 1.91
Helping: business quality, durable growth, positive momentum
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 42 | Weak | |
| 42 | Weak | |
| 42 | Weak | |
| 42 | Weak | |
| 42 | Weak | |
| 42 | Weak |
Daily score refresh is delayed. This is the last recorded calculation.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $137.81 | |
| Change on the day | +2.38% | |
| 52-week range | $69.51 – $144.35 | |
| Market capitalisation | $775M | — |
| Price / earnings (trailing) | 114.07 | |
| Shares traded on the day | 74.9K |
Price & events
Other perspectives
Council score for Mesa Laboratories (MLAB): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
4 lenses, 4 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 20, 2026
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Nov 18, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Nov 18, 2026, the Munger lens read the price at that time as overvalued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Mesa Laboratories (MLAB), and what does it report?
Short answer
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Mesa Laboratories, Inc. (MLAB) is listed on NASDAQ. It employs 717 people and is led by Siddhartha C. Kadia. The market values it at $775M.
What do the latest results show for Mesa Laboratories (MLAB)?
Short answer · as of
Against analyst estimates the company has EPS beat 1 of the last 4 reports.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Sep 2025 | $61M | $2M | $0.45 (diluted) |
| Q3 FY2026 | $65M | $4M | $0.65 (diluted) |
| Q4 FY2026 | $64M | -$4M | -$0.75 (diluted) |
| Q1 FY2027 | $60M | $3M | $0.49 (diluted) |
What are the financial strengths and risks for Mesa Laboratories (MLAB)?
Short answer
The MoonshotScore pillars rate business quality, durable growth, positive momentum as strengths. The distress and quality screens read Altman Z 2.43 · Piotroski F 7. Trailing ratios: ROE 3.6% · ROA 3.9% · current ratio 1.91.
What should you watch next at Mesa Laboratories (MLAB)?
Short answer · as of
Current published price targets run low $110.00 · high $110.00 · consensus $110.00 · median $110.00 against a quoted price of $137.81 (as of Nov 18, 2026).
What the records here don't tell us
- No forward revenue or earnings estimate is on file.
- The next earnings date is not yet scheduled in the calendar we read.
- No insider Form 4 transaction falls inside the window this page reads.
Checked against the records this page reads, on the dates shown above.
How does Mesa Laboratories compare with its peers?
Short answer
Mesa Laboratories's score ranks 4th of 6 in the bounded comparison shown, against 5 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
| Company | Price | Market value | Score |
|---|---|---|---|
| $692.74 Nov 18, 2026 | $257B | 70 5-pillar Nov 18, 2026 | |
| $181.05 Nov 18, 2026 | $93.6B | 66 5-pillar Nov 18, 2026 | |
| $1.12 Nov 18, 2026 | $75.1M | 45 5-pillar Nov 18, 2026 | |
| Mesa Laboratories (MLAB) — this page | $137.81 | $775M | 42 |
| $20.65 Nov 18, 2026 | $432M | 34 5-pillar Nov 18, 2026 | |
| $1.57 Nov 18, 2026 | $11.5M | 29 5-pillar Nov 18, 2026 | |
| $115.24 Sep 11, 2026 | $14.5B | — Model unavailable |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $110.00 – $110.00
- Consensus target
- $110.00
- Median target
- $110.00
Consensus record · Captured .
Measured against a quoted price of $137.81 (as of Nov 18, 2026).
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held MLAB in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported MLAB in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about Mesa Laboratories (MLAB)?
- Sterilization Monitoring Technologies - Global Strategic Business Report 2026: Secure Share of the $1 Billion Market by 2032 | Features Competitive Intelligence on 3M, Steris, Getinge, Cardinal Health and Mesa Laboratories
- Mesa Laboratories Inc (MLAB) Q2 2027 Earnings Call Highlights: Margin Expansion and ...
- Mesa Laboratories, Inc. Q2 2027 Earnings Call Summary
- Mesa Labs (MLAB) Q2 2027 Earnings Call Transcript
Common Questions About MLAB
These answers are editorial: 1 of these 9 answers is drawn from the MLAB research dossier (written May 10, 2026 by gpt-4o-mini); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.
What does the MoonshotScore mean for MLAB?
MLAB carries the MoonshotScore stated above — the Weak band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.
Is MLAB a good stock to buy?
Stock Expert AI does not rate MLAB buy, sell or hold. Mesa Laboratories, Inc. carries a MoonshotScore, in the Weak band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the MLAB stock price today?
The last price recorded for Mesa Laboratories, Inc. (MLAB), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the MLAB price target?
The analyst consensus price target for Mesa Laboratories, Inc. (MLAB), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
What are the main risks for MLAB?
Mesa Laboratories faces several risks, including regulatory challenges that could delay product approvals and market entry. Additionally, intense competition from larger players in the life sciences sector poses a threat, along with potential economic downturns that may impact healthcare spending and investment.
What are the key factors to evaluate for MLAB?
Mesa Laboratories, Inc. (MLAB) holds a MoonshotScore in the low range. To weigh it, compare the trailing P/E under Price & valuation with the analyst view under Analyst targets & estimates on this page. Mesa's automated systems for protein analysis and peptide synthesis are well-positioned to meet the increasing demand for innovative therapies and research solutions. Not financial advice.
How frequently does MLAB data refresh on this page?
MLAB's price is the last quote we recorded, from the Nov 18, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven MLAB's recent stock price performance?
Mesa Laboratories, Inc. (MLAB) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse product portfolio across multiple life sciences segments. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider MLAB overvalued or undervalued right now?
The trailing P/E of Mesa Laboratories, Inc. (MLAB) is listed under Price & valuation, and the analyst consensus target under Analyst targets & estimates, on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 17 figures on this page — 10 from Financial Modeling Prep (FMP), 6 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com